Statement from FDA Confirms Approval of Gilead's Zydelig By: Benzinga via Benzinga July 23, 2014 at 11:46 AM EDT The U.S. Food and Drug Administration today approved Zydelig (idelalisib) to treat patients with three types of blood ... Read More >> Related Stocks: Gilead Sciences